Symptoms of Low Manganese: Causes and Treatment
Deficiency
Symptoms & causes
Manganese is an essential trace mineral required for bone formation, antioxidant defense (MnSOD), and carbohydrate/amino acid metabolism — true deficiency is rare in humans eating any varied diet, but excess manganese (neurotoxicity) is a more clinically relevant concern than deficiency.
Manganese deficiency is practically nonexistent in free-living adults who eat any variety of whole grains, legumes, nuts, or leafy greens. The symptoms described in medical literature come from experimental depletion studies, not spontaneous cases. The more clinically relevant concern is manganese toxicity, or manganism, which can occur from occupational exposure or excessive supplement intake and mimics Parkinson's disease.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Manganese (Mn) — an essential trace mineral serving as a cofactor or activator for multiple metalloenzymes: manganese superoxide dismutase (MnSOD — mitochondrial antioxidant defense), arginase (urea cycle), pyruvate carboxylase (gluconeogenesis), and manganese-containing enzymes in cartilage synthesis (glycosyltransferases). Also required for normal bone formation and wound healing. AI (Adequate Intake, not RDA — insufficient data for RDA): 1.8 mg/day women; 2.3 mg/day men. UL: 11 mg/day adults (from all sources including food, supplements, and water). Widely distributed in plant foods — true dietary deficiency in healthy individuals eating any varied diet is very rare.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Dermatitis (skin inflammation)
- Nausea
- Changes in hair color (depigmentation)
- Altered cholesterol metabolism
- Impaired bone metabolism
- Impaired carbohydrate tolerance
Don't wait
See a doctor if
- Not applicable to dietary manganese deficiency (too rare to have a standard of care pathway).
- Discuss with a clinician if on long-term TPN (manganese must be monitored in TPN — both for deficiency AND toxicity, as TPN-associated manganese accumulation causing brain toxicity is a documented complication).
- Seek care for signs of excess manganese toxicity if occupationally exposed.
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- No meaningful at-risk population for dietary manganese deficiency in the general population — manganese is ubiquitous in plant foods.
- TPN-dependent patients are the exception.
- The clinically more relevant risk group is for TOXICITY: occupational exposure (welders, smelters, miners exposed to manganese dust/fumes); excessive supplement intake (manganese in high-dose supplements or contaminated water supplies); patients on TPN who receive excess manganese (MRI-detectable brain accumulation documented).
What causes low Manganese (Mn) — an essential trace mineral serving as a cofactor or activator for multiple metalloenzymes: manganese superoxide dismutase (MnSOD — mitochondrial antioxidant defense), arginase (urea cycle), pyruvate carboxylase (gluconeogenesis), and manganese-containing enzymes in cartilage synthesis (glycosyltransferases). Also required for normal bone formation and wound healing. AI (Adequate Intake, not RDA — insufficient data for RDA): 1.8 mg/day women; 2.3 mg/day men. UL: 11 mg/day adults (from all sources including food, supplements, and water). Widely distributed in plant foods — true dietary deficiency in healthy individuals eating any varied diet is very rare.
- Severely restricted diet excluding whole grains, legumes, nuts, seeds, and leafy vegetables (the richest manganese sources)
- Long-term total parenteral nutrition (TPN) without manganese
- Severe malabsorptive disease (rare)
How low levels are diagnosed
Serum manganese levels (not a reliable indicator of tissue status — whole blood manganese more accurate); no standard clinical test for deficiency in free-living individuals. MRI (T1-weighted) can detect manganese accumulation in the basal ganglia in toxicity cases.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
For experimental deficiency: restore dietary manganese sources — whole grains (wheat, oat), legumes (chickpeas, black beans), nuts (hazelnuts, macadamia), pineapple, leafy greens. Typical manganese content: hazelnuts ~1.6 mg/oz; cooked oatmeal ~1.4 mg/cup; canned chickpeas ~0.9 mg/½ cup. Most multivitamins contain 1.5–2.5 mg manganese; separate manganese supplements are rarely needed and carry toxicity risk if combined with dietary intake near the UL.
How to keep levels up
Dietary variety including whole grains, nuts, legumes, and leafy greens is sufficient for virtually all free-living adults. Avoid excessive supplemental manganese above 11 mg/day UL; be cautious with high-manganese well water in certain regions.
When to see a clinician
For suspected TPN-associated manganese toxicity (parkinsonism-like symptoms in TPN patients): urgent referral. For occupational manganese exposure symptoms (tremor, rigidity, emotional changes — early manganism): occupational medicine referral. For dietary deficiency in free-living individuals: discuss with dietitian only if severely restricted diet confirmed; standard medical workup is unlikely to be indicated.
Manganese Deficiency Is Practically Nonexistent in Free-Living Adults — Here Is Why
If you're searching for symptoms of low manganese, you've likely encountered supplement marketing that makes deficiency sound like a widespread threat. The reality is starkly different: manganese deficiency is one of the rarest micronutrient deficiencies in humans, and spontaneous cases in free-living adults eating any variety of food are essentially nonexistent.
Manganese is ubiquitous in the plant food supply. Whole grains, legumes, nuts, seeds, and leafy greens all supply meaningful amounts. A single cup of cooked oatmeal delivers roughly 1.4 mg of manganese — about 60% of the daily Adequate Intake for men and nearly 80% for women. A one-ounce serving of hazelnuts provides approximately 1.6 mg. Even a modest diet that includes a bowl of oatmeal, a handful of nuts, and a salad with chickpeas easily exceeds the AI of 1.8 mg for women and 2.3 mg for men.
The symptoms of manganese deficiency you may read about — dermatitis, nausea, hair depigmentation, altered cholesterol metabolism, and impaired bone formation — come from tightly controlled metabolic ward studies conducted decades ago. In these experiments, volunteers consumed purified diets deliberately stripped of manganese. No free-living person ever eats this way. The NIH Office of Dietary Supplements confirms that a clinical deficiency syndrome has never been observed in the general population eating a varied diet.
This stands in sharp contrast to genuinely common trace mineral deficiencies. Iron deficiency affects roughly 25% of the global population. Zinc deficiency is widespread in regions dependent on cereal-based diets. Iodine deficiency remains a major public health concern for an estimated two billion people. Manganese deficiency simply does not belong on this list. The World Health Organization does not prioritize it as a global micronutrient problem, and for good reason — the food supply makes it nearly impossible to become deficient.
Bottom line
Unlike iron or zinc, which affect millions through inadequate diets, manganese deficiency in any person eating a diet with grains, legumes, or nuts is essentially theoretical — eating a single cup of oatmeal provides ~60% of the daily AI.
What Manganese Actually Does in the Body: MnSOD, Bone, and Carbohydrate Metabolism
Manganese earns its essential status through several critical biochemical roles, and understanding them explains why it appears in joint supplements and why deficiency disrupts multiple systems.
The most important role is as a component of manganese superoxide dismutase (MnSOD), the primary antioxidant enzyme inside your mitochondria. Every cell's mitochondria generate superoxide radicals as a byproduct of energy production. MnSOD neutralizes these radicals before they damage mitochondrial DNA and membranes. Without adequate manganese, this antioxidant defense weakens, leaving cells more vulnerable to oxidative stress — which is why experimental deficiency produces such widespread effects.
Manganese also serves as a cofactor for arginase, the enzyme that completes the urea cycle by converting arginine to urea and ornithine. This makes manganese essential for ammonia disposal and protein metabolism. Additionally, it activates pyruvate carboxylase, a key enzyme in gluconeogenesis — the process of making new glucose from non-carbohydrate sources. This explains why experimental manganese depletion disrupts carbohydrate tolerance and alters blood lipid profiles.
The role most relevant to supplement marketing is manganese's function in glycosyltransferases, enzymes that synthesize proteoglycans — the protein-sugar complexes that form the structural framework of cartilage and bone. This is the biochemical rationale for including manganese in glucosamine and chondroitin formulas. The logic is sound: manganese is genuinely required for building the cartilage matrix. However, as we'll explore, whether adding extra manganese to a joint supplement provides additional clinical benefit beyond what dietary manganese already supplies is a separate question that the evidence has not clearly answered.
Bottom line
Manganese's most important physiological role for human health is as the mitochondrial antioxidant cofactor (MnSOD) and a component of cartilage/bone synthesis enzymes — the joint-health supplement marketing is built on a real biochemical rationale.
The Manganese Paradox: Toxicity Is a Bigger Clinical Problem Than Deficiency
Here is the central finding that most supplement-focused content avoids: the real clinical story with manganese is not deficiency but toxicity. Manganism — manganese accumulation in the basal ganglia of the brain — produces a Parkinson's-like syndrome that clinicians encounter far more often than manganese deficiency.
Occupational exposure is the primary concern. Welders, smelters, and manganese ore miners inhale manganese dust and fumes that bypass the body's normal gastrointestinal regulation of absorption. Once manganese enters the bloodstream through the lungs, it can cross the blood-brain barrier and deposit in the globus pallidus and other basal ganglia structures. The resulting syndrome includes tremor, rigidity, gait disturbance, dysarthria, and psychiatric changes — a clinical picture that can be difficult to distinguish from idiopathic Parkinson's disease. OSHA recognizes this as a significant occupational health hazard.
Total parenteral nutrition (TPN) presents a dual risk. Patients on long-term TPN need manganese to prevent deficiency, but they are also vulnerable to accumulation because the intravenous route bypasses intestinal absorption controls. MRI studies have documented manganese deposition in the basal ganglia of TPN patients receiving standard manganese doses, sometimes before clinical symptoms appear. Current ASPEN and ESPEN guidelines recommend monitoring manganese levels in TPN patients and adjusting supplementation accordingly.
The tolerable upper intake level (UL) of 11 mg per day for adults exists specifically because of neurotoxicity concerns, not theoretical deficiency prevention. This UL includes manganese from all sources — food, supplements, and water. A person eating a manganese-rich diet (whole grains, nuts, legumes, tea) might consume 3 to 5 mg from food alone. Adding a multivitamin with 2 mg and a joint supplement with another 2 to 5 mg can push total intake toward or beyond the UL. Well water in certain regions can add additional manganese. The cumulative exposure is what matters, and few supplement labels warn about this stacking effect.
Bottom line
Manganism (manganese neurotoxicity) is a recognized occupational and TPN-related clinical syndrome; excess manganese from supplements stacked on dietary intake can approach the UL — the toxicity story is clinically more relevant than the deficiency story for most supplement consumers.
Manganese in Joint Health Supplements: What the Glucosamine-Chondroitin Evidence Says
Walk down any pharmacy supplement aisle and you'll find manganese listed alongside glucosamine and chondroitin in joint health formulas. The biochemical rationale is legitimate: manganese-dependent glycosyltransferases build the proteoglycan matrix of cartilage. But does adding manganese to these formulas actually improve joint pain or function?
The landmark GAIT trial, published in the New England Journal of Medicine in 2006, tested glucosamine, chondroitin sulfate, and the combination against placebo in nearly 1,600 patients with knee osteoarthritis. The overall results were negative — neither glucosamine nor chondroitin alone nor the combination significantly reduced pain compared to placebo in the full study population. However, a pre-specified subgroup analysis found that patients with moderate-to-severe knee pain experienced a statistically significant benefit from the combination.
Critically, the GAIT trial and subsequent studies tested these products as combined formulas. Manganese's independent contribution to any observed benefit has never been isolated in a human trial. We cannot say whether the manganese component adds anything beyond what glucosamine and chondroitin provide, or whether the same results would occur without it. The manganese is included because of its known biochemical role, not because clinical trials have demonstrated that adding it improves outcomes.
For people taking multiple joint supplements, the practical concern is total manganese intake. A typical glucosamine-chondroitin-manganese formula might contain 2 to 5 mg of manganese per daily dose. Combined with a multivitamin (1.5 to 2.5 mg) and a diet rich in whole grains and nuts (3 to 5 mg), total intake can approach or exceed the 11 mg UL. This is not an acute toxicity risk — manganism develops over months to years of excess exposure — but it is an unnecessary and avoidable cumulative burden. If you take joint supplements, check the label for manganese content and calculate your total from all sources.
Bottom line
Manganese is in joint supplements because of its cartilage-synthesis enzyme role — but its independent clinical contribution has not been isolated in trials; people taking multiple joint supplements should check total manganese from all sources against the 11 mg/day UL.
Manganese and GLP-1 Therapy: Bone Health During Rapid Weight Loss
Rapid weight loss, including the significant reductions achieved with GLP-1 receptor agonists like semaglutide and tirzepatide, raises legitimate questions about bone health. Studies of bariatric surgery and very-low-calorie diets have documented reductions in bone mineral density during periods of rapid weight loss, and the same concern applies to pharmacologically induced weight reduction.
Manganese contributes to bone matrix synthesis through its role in proteoglycan-producing enzymes, so it is reasonable to ask whether GLP-1 users need to worry about manganese status. The practical answer is reassuring: the foods richest in manganese — whole grains, legumes, nuts, and leafy greens — are not foods that GLP-1 users typically eliminate. Even with reduced appetite and caloric intake, most people continue to eat some oatmeal, whole-grain bread, beans, or nuts. A single serving of any of these provides a substantial fraction of the daily manganese AI.
The more important bone health priorities during GLP-1 therapy are calcium and vitamin D. Adequate calcium intake (1,000 to 1,200 mg per day from diet plus supplements if needed) and vitamin D status (targeting serum 25-hydroxyvitamin D above 30 ng/mL) have far more evidence supporting their role in bone preservation during weight loss than manganese does. Weight-bearing exercise — walking, resistance training, stair climbing — provides mechanical loading that signals bone to maintain density. These interventions address the primary drivers of bone loss during caloric deficit.
There is no known drug interaction between manganese and semaglutide or tirzepatide. Separate manganese supplementation is not indicated for GLP-1 users who maintain any dietary variety. If you are already taking a multivitamin or joint supplement containing manganese, your needs are more than covered. The focus should remain on overall nutritional adequacy — protein intake to preserve lean mass, calcium and vitamin D for bone, and dietary variety that naturally supplies manganese and other trace minerals.
Bottom line
Bone density loss during GLP-1-induced rapid weight loss is a real concern — but calcium and vitamin D are the priority interventions; manganese deficiency risk is essentially nil if any whole grains, legumes, or nuts remain in the diet.
What most pages leave out
The biggest honesty gap in competitor manganese content is the omission of the toxicity story — supplement content exclusively covers deficiency without mentioning that manganese neurotoxicity (manganism) is the clinical concern more commonly encountered by clinicians. The UL (11 mg/day) is frequently exceeded by people combining manganese-containing joint supplements with manganese-fortified multivitamins and manganese-rich diets.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
Based on experimental depletion studies, symptoms include dermatitis, nausea, hair depigmentation, impaired bone formation, and altered carbohydrate metabolism. However, true spontaneous deficiency in free-living adults eating varied diets essentially does not occur.
The Adequate Intake (AI) is 1.8 mg/day for women and 2.3 mg/day for men. This is easily met by a cup of cooked oatmeal or a small serving of nuts.
The richest sources are whole grains (oatmeal), nuts (hazelnuts, macadamia, pecans), legumes (chickpeas, black beans), leafy greens (spinach), pineapple, and tea.
Yes. The tolerable upper limit is 11 mg/day for adults. Excess manganese accumulates in the brain and can cause manganism, a Parkinson's-like neurological syndrome. Always check total manganese from diet plus all supplements.
It is a cofactor for proteoglycan-synthesizing enzymes in cartilage. The biochemical rationale is sound, but the specific clinical contribution of the manganese component in joint supplement trials has not been isolated.
Yes, especially for welders, miners, and people with high occupational exposure. It is also a concern in TPN patients and those taking multiple manganese-containing supplements that approach the 11 mg/day upper limit.
No. Manganese is one of the least common micronutrient deficiencies in people eating any food variety. The WHO does not list it as a significant global public health concern compared to iron, zinc, iodine, or vitamin A.
There is no known drug interaction. Separate manganese supplements are rarely needed for GLP-1 users maintaining any dietary variety. Check your total manganese intake if you are already taking joint supplements or multivitamins.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
What Are the Symptoms of Low Aloe Vera? Causes and Treatment
Aloe vera is a plant, not a nutrient—no deficiency exists. Learn the critical gel vs. latex safety distinction, FDA actions, and oral use risks for GLP-1 users.
Read moreSymptoms of Low Barley Grass: Why This Isn’t a Real Deficiency
Barley grass is a plant food, not an essential nutrient. There is no barley grass deficiency. Learn what it actually contains, what the weak evidence shows, and the real safety risks.
Read moreSymptoms of Low 5-HTP (5-Hydroxytryptophan): Causes & Treatment
5-HTP is a serotonin precursor, not a nutrient you can be deficient in. Learn what low serotonin activity means, the real risks of 5-HTP supplements, and safer alternatives.
Read moreSymptoms of Low Astaxanthin: Causes and Treatment
Astaxanthin is a powerful antioxidant found in salmon and shrimp, but there's no such thing as a deficiency. Learn what low intake actually means and what the science says.
Read moreSymptoms of Low Apple Cider Vinegar: Causes and Treatment
Apple cider vinegar is a condiment, not a nutrient — no deficiency syndrome exists. Learn what the research actually shows about ACV, blood sugar, and safety risks.
Read moreSymptoms of Low Ashwagandha: Causes and Treatment
Ashwagandha is an adaptogenic herb, not a nutrient. No deficiency syndrome exists. Learn what the evidence shows for stress, thyroid, and safety risks like thyrotoxicosis.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.